Value-Based Contracting Needs Federal Safe Harbors To Flourish, Lilly Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly USA Deputy General Counsel Weems and former Anthem Chief Medical Officer Nussbaum offer insights on how guidance from the HHS Inspector General might help advance value-based contracting.
You may also be interested in...
HHS Advancing Attack On Rebates With Proposal To Revoke Safe Harbor
Upcoming proposed rule could also provide new anti-kickback safe harbor to facilitate value-based contracts, as manufacturers and payers have urged.
HHS Action On Drug Pricing: Here's Who Secretary Price Is Listening To
HHS is expected to move ahead with action to address high drug prices following a series of stakeholder roundtables held over the past month.
Where Will It End? Lilly’s US Price Concessions Increase 30% In 2016
Eli Lilly recorded $7.69bn in rebates and discounts in the US in 2016 as pharmacy benefit managers demanded greater price concessions in crowded categories like diabetes.